152 related articles for article (PubMed ID: 21537383)
1. Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis.
Mercer KE; Apostolov EO; Gamboa da Costa G; Yu X; Lang P; Roberts DW; Davis W; Basnakian AG; Kadlubar FF; Kadlubar SA
Int J Mol Epidemiol Genet; 2010 Jan; 1(2):92-103. PubMed ID: 21537383
[TBL] [Abstract][Full Text] [Related]
2. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
3. Frequency distribution of phenol sulfotransferase 1A1 activity in platelet cells from healthy Japanese subjects.
Ohtake E; Kakihara F; Matsumoto N; Ozawa S; Ohno Y; Hasegawa S; Suzuki H; Kubota T
Eur J Pharm Sci; 2006 Jul; 28(4):272-7. PubMed ID: 16621480
[TBL] [Abstract][Full Text] [Related]
4. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
5. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.
Nagar S; Walther S; Blanchard RL
Mol Pharmacol; 2006 Jun; 69(6):2084-92. PubMed ID: 16517757
[TBL] [Abstract][Full Text] [Related]
6. SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
BMC Cancer; 2012 Jun; 12():257. PubMed ID: 22708928
[TBL] [Abstract][Full Text] [Related]
7. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1.
Aust S; Jaeger W; Klimpfinger M; Mayer K; Baravalle G; Ekmekcioglu C; Thalhammer T
J Pineal Res; 2005 Oct; 39(3):276-82. PubMed ID: 16150108
[TBL] [Abstract][Full Text] [Related]
9. Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.
Arslan S; Silig Y; Pinarbasi H
Exp Ther Med; 2011 Nov; 2(6):1159-1162. PubMed ID: 22977637
[TBL] [Abstract][Full Text] [Related]
10. Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.
Falany JL; Pilloff DE; Leyh TS; Falany CN
Drug Metab Dispos; 2006 Mar; 34(3):361-8. PubMed ID: 16381672
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
[TBL] [Abstract][Full Text] [Related]
12. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance.
Samaddar JS; Gaddy VT; Duplantier J; Thandavan SP; Shah M; Smith MJ; Browning D; Rawson J; Smith SB; Barrett JT; Schoenlein PV
Mol Cancer Ther; 2008 Sep; 7(9):2977-87. PubMed ID: 18790778
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.
Rohn KJ; Cook IT; Leyh TS; Kadlubar SA; Falany CN
Drug Metab Dispos; 2012 Aug; 40(8):1588-95. PubMed ID: 22593037
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
Obrero M; Yu DV; Shapiro DJ
J Biol Chem; 2002 Nov; 277(47):45695-703. PubMed ID: 12244117
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
Cheng J; Yu DV; Zhou JH; Shapiro DJ
J Biol Chem; 2007 Oct; 282(42):30535-43. PubMed ID: 17716978
[TBL] [Abstract][Full Text] [Related]
17. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
18. Effects of SULT1A1 Copy Number Variation on Estrogen Concentration and Tamoxifen-Associated Adverse Drug Reactions in Premenopausal Thai Breast Cancer Patients: A Preliminary Study.
Charoenchokthavee W; Ayudhya DP; Sriuranpong V; Areepium N
Asian Pac J Cancer Prev; 2016; 17(4):1851-5. PubMed ID: 27221864
[TBL] [Abstract][Full Text] [Related]
19. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.
Gauduchon J; Gouilleux F; Maillard S; Marsaud V; Renoir JM; Sola B
Clin Cancer Res; 2005 Mar; 11(6):2345-54. PubMed ID: 15788686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
